Drug Shortage Report for MINT-EZETIMIBE
Report ID | 27176 |
Drug Identification Number | 02423243 |
Brand name | MINT-EZETIMIBE |
Common or Proper name | Ezetimibe |
Company Name | MINT PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | EZETIMIBE |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | Bottles of 100 |
ATC code | C10AX |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Shortage of an inactive ingredient or component. |
Anticipated start date | |
Actual start date | 2017-07-24 |
Estimated end date | Unknown |
Actual end date | 2017-11-10 |
Shortage status | Resolved |
Updated date | 2017-11-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-10-26 | English | Compare |
v2 | 2017-10-26 | French | Compare |
v3 | 2017-11-10 | English | Compare |
v4 | 2017-11-10 | French | Compare |
v5 | 2017-11-11 | English | Compare |
Showing 1 to 5 of 5